810209 | C6-NBD Ceramide

N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-erythro-sphingosine


Powder

Size SKU Packaging Price
1mg 810209P-1mg 810209P-1mg 1 x 1mg $386.40

Chloroform/Methanol

Size SKU Packaging Price
1mg 810209X-1mg 810209X-1mg 1 x 1mg 1mg/mL 1mL $386.40
Base Price: ${originalprice|money}
Custom Packaging: (${concentration} @$4.00/ea. + $100) ${custompackagingtotal|money}
Packaging: ${concentration}
Item Total: ${totalprice|money}
Please select an option above.
${sku} - ${concentration}

C6-NBD Ceramide

C6-NBD Ceramide

N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-erythro-sphingosine

Hygroscopic
Yes
Light Sensitive
Yes
Molecular Formula
C30H49N5O6
Percent Composition
C 62.58%, H 8.58%, N 12.16%, O 16.67%
Purity
>99%
Stability
1 Year
Storage Temperature
-20°C
CAS Number
94885-02-6
CAS Registry Number is a Registered Trademark of the American Chemical Society
Formula Weight
575.740
Exact Mass
575.368

Mitrofanova A, Mallela SK, Ducasa GM, Yoo TH, Rosenfeld-Gur E, Zelnik ID, Molina J, Varona Santos J, Ge M, Sloan A, Kim JJ, Pedigo C, Bryn J, Volosenco I, Faul C, Zeidan YH, Garcia Hernandez C, Mendez AJ, Leibiger I, Burke GW, Futerman AH, Barisoni L, Ishimoto Y, Inagi R, Merscher S, Fornoni A. SMPDL3b modulates insulin receptor signaling in diabetic kidney disease. Nat Commun. 2019 Jun 19;10(1):2692. doi: 10.1038/s41467-019-10584-4.

PubMed ID: 31217420

Glasgow BJ, Abduragimov AR. Methods toward simplification of time resolved fluorescence anisotropy in proteins labeled with NBD (4-chloro-7-nitrobenzofurazan) adducts. MethodsX. 2019 Apr 29;6:998-1008. doi: 10.1016/j.mex.2019.04.025. eCollection 2019.

PubMed ID: 31080764

Suhrland C, Truman JP, Obeid LM, Sitharaman B. Oxidized graphene nanoparticles as a delivery system for the pro-apoptotic sphingolipid C6 ceramide. J Biomed Mater Res A. 2019 Jan;107(1):25-37. doi: 10.1002/jbm.a.36474. Epub 2018 Nov 13.

PubMed ID: 30422374